LOTTE BIOLOGICS Accelerates Global CDMO Expansion with Dual Manufacturing Bases in North America and Asia, and Next-Generation ADC Modalities

■    Strengthening strategic partnerships and expanding client base through North America-Asia manufacturing hubs

■    Targeting the global CDMO market with quality competitiveness and proven global manufacturing track record

LOTTE BIOLOGICS (CEO James Park) is accelerating its growth as a global CDMO (Contract Development and Manufacturing Organization) company.
 

link : https://www.biospace.com/lotte-biologics-accelerates-global-cdmo-expansion-with-dual-manufacturing-bases-in-north-america-and-asia-and-next-generation-adc-modalities